Summary of Significant Accounting Policies - Segments (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2021 USD ($) segment	Dec. 31, 2020 USD ($)
Medical Indication Information
Number of reportable segments | segment			1
Total net sales	$ 86,508	$ 133,920	$ 188,033	$ 260,399
Analgesic
Medical Indication Information
Total net sales	3,919	3,572	9,233	6,692
Anti-Psychosis
Medical Indication Information
Total net sales	2,095	13,317	5,810	26,345
Cardiovascular
Medical Indication Information
Total net sales	9,753	16,336	23,853	36,050
Central Nervous System
Medical Indication Information
Total net sales	22,340	24,614	45,125	47,139
Endocrinology
Medical Indication Information
Total net sales	8,297	9,496	16,142	12,729
Gastrointestinal
Medical Indication Information
Total net sales	14,023	18,575	29,263	35,675
Infectious Disease
Medical Indication Information
Total net sales	6,520	23,044	19,035	44,976
Migraine
Medical Indication Information
Total net sales	4,446	6,083	9,131	15,773
Respiratory/Allergy/Cough/Cold
Medical Indication Information
Total net sales	1,868	2,267	4,982	3,693
Urinary
Medical Indication Information
Total net sales	1,164	1,361	2,340	2,819
Other
Medical Indication Information
Total net sales	9,111	8,410	18,287	16,044
Contract manufacturing revenue
Medical Indication Information
Total net sales	$ 2,972	$ 6,845	$ 4,832	$ 12,464